What the Clinical Data Says About Extended Treatment The backbone of everything we know about extended Retatrutide use comes from the Phase 2 SURMOUNT-1 trial, which tracked 338 participants across multiple dose groups for a full 48 weeks
With GLP-1based therapies, lower calorie intake, poor protein intake, inactivity, and rapid weight reduction can all contribute to lean-mass loss
This third effectthe slowing of digestionis a primary reason why medications like Ozempic are so effective for weight loss
This antioxidant and its associated enzymes can efficiently bind a wide range of toxins , including reactive oxygen species, peroxides, lipid peroxides, and heavy metals
The trade-off is the inconvenience of more frequent injections and potentially faster use of supplies